These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bayesian meta-analyses for comparative effectiveness and informing coverage decisions. Berry SM; Ishak KJ; Luce BR; Berry DA Med Care; 2010 Jun; 48(6 Suppl):S137-44. PubMed ID: 20473185 [TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research. Lam KC; Bacon CEW; Sauers EL; Bay RC J Athl Train; 2020 Mar; 55(3):217-228. PubMed ID: 31618071 [TBL] [Abstract][Full Text] [Related]
5. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis". Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534 [TBL] [Abstract][Full Text] [Related]
6. Bayesian data analysis in observational comparative effectiveness research: rationale and examples. Olson WH; Crivera C; Ma YW; Panish J; Mao L; Lynch SM J Comp Eff Res; 2013 Nov; 2(6):563-71. PubMed ID: 24236795 [TBL] [Abstract][Full Text] [Related]
7. Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study. Connor JT; Luce BR; Broglio KR; Ishak KJ; Mullins CD; Vanness DJ; Fleurence R; Saunders E; Davis BR Clin Trials; 2013 Oct; 10(5):807-27. PubMed ID: 23983160 [TBL] [Abstract][Full Text] [Related]
9. Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness research. Agapova M; Devine EB; Nguyen H; Wolf FM; Inoue LY J Comp Eff Res; 2014 Jul; 3(4):345-57. PubMed ID: 25275232 [TBL] [Abstract][Full Text] [Related]
10. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization. Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191 [TBL] [Abstract][Full Text] [Related]
11. Bayesian meta-analysis on medical devices: application to implantable cardioverter defibrillators. Youn JH; Lord J; Hemming K; Girling A; Buxton M Int J Technol Assess Health Care; 2012 Apr; 28(2):115-24. PubMed ID: 22559753 [TBL] [Abstract][Full Text] [Related]
12. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial. Cunanan KM; Carlin BP; Peterson KA Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710 [TBL] [Abstract][Full Text] [Related]
13. Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution. Luce BR; Connor JT; Broglio KR; Mullins CD; Ishak KJ; Saunders E; Davis BR; Ann Intern Med; 2016 Sep; 165(6):431-8. PubMed ID: 27273013 [TBL] [Abstract][Full Text] [Related]
14. Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for clinicians. Kalil AC; Sun J Crit Care Med; 2014 Oct; 42(10):2267-77. PubMed ID: 25226118 [TBL] [Abstract][Full Text] [Related]
15. On the interplay of machine learning and background knowledge in image interpretation by Bayesian networks. Velikova M; Lucas PJ; Samulski M; Karssemeijer N Artif Intell Med; 2013 Jan; 57(1):73-86. PubMed ID: 23395008 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909 [TBL] [Abstract][Full Text] [Related]
17. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree. Shen C; Hu Y; Li X; Wang Y; Chen PS; Buxton AE Biom J; 2016 Nov; 58(6):1357-1375. PubMed ID: 27356196 [TBL] [Abstract][Full Text] [Related]
18. Leveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical Research. Kim DD; Trikalinos TA; Wong JB Med Decis Making; 2019 Feb; 39(2):119-129. PubMed ID: 30678537 [TBL] [Abstract][Full Text] [Related]
19. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. Kruse G; Wong BJ; Duh MS; Lefebvre P; Lafeuille MH; Fastenau JM Pharmacoeconomics; 2015 Oct; 33(10):1049-67. PubMed ID: 25963579 [TBL] [Abstract][Full Text] [Related]